News, Events & Publications

News, Events & Publications

News & Events

  • European Standard of Clinical Practice (ESCP)

    The ESCP Project is an on-going collaboration between ERN PaedCan and SIOP Europe’s Clinical Trial Groups (ECTG), aiming to develop approved clinical recommendations that reflect current best practices for each common childhood cancer type. Read more

  • Clinical Patient Management System (CPMS)

    Healthcare providers who are members of ERNs are connected through a dedicated IT platform and, using a variety of telemedicine tools, offer access to expertise and knowledge of multidisciplinary teams, enabling patients to receive the best advice for treatment and diagnosis. Read more

  • Rare Disease Day – EU Booklet

    Ahead of the Rare Disease Day, the European Commission will publish a booklet celebrating the dedication and expertise of the European Reference Networks that make a tangible difference to the lives of patients with rare diseases and their families.nnTwo new factsheets will also be available on how the European Commission works on Rare Diseases and the… Read more

  • High-Level Meeting on a European Research and Innovation Ecosystem for Rare Diseases

    The High-Level Meeting (HLM)on a European research and Innovation ecosystem for rare diseases will take place on December 9-11, 2025 in Brussels.This three-day event will gather key stakeholders, including EU policymakers, industry leaders, patient advocacy groups, researchers, and healthcare providers. The goal is to identify concrete actions and incentives to enhance innovation across the rare… Read more

  • 6th International Symposium for Childhood Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL)

    The 6th International Symposium for Childhood Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL) will take place in Berlin, Germany, October 15-18,2025. The symposium target audience: Scientists and clinicians involved in the research and treatment of Hodgkin lymphoma in children, adolescents, and young adults. The Focus areas: Survivorship outcomes, global clinical trial portfolios, novel therapeutic biomarkers, advances in… Read more

  • 11th Biannual EWOG-MDS/SAA Symposium

    The 11th Biannual EWOG-MDS/SAA Symposium will take place in September 18-20 2025 in Berlin, Germany. We invite you to participate in person or virtual (presentations available on demand for 3 months) The abstract deadline is June 15, 2025. Under the motto “On the verge of malignancy: Cytopenia and Beyound” International experts will present and discuss novel… Read more

Publications

Scientific Publications
DateNo. Of HCPsTypeList of Publications that aknowledge PaedCanDOIPDFERN PaedCan HCPs Keywords
2025HealthcareDifferences in care delivery for children and adolescents with cancer in Europe – Results from the SIOPE OCEAN projecthttps://doi.org/10.1038/s41409-021-01374-y
2025ESCP GuidelineEuropean clinical practice recommendations for the diagnosis and treatment of paediatric pineal tumourshttps://doi.org/10.1016/j.ejcped.2025.100217
2025ESCP GuidelineAn overview of the European standard clinical practice recommendations for choroid plexus tumourshttps://doi.org/10.1016/j.ejcped.2025.100226
2025ESCP GuidelineEuropean standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescencehttps://doi.org/10.1016/j.ejcped.2025.100227
Ependymoma 
2025ESCP GuidelineEuropean standard clinical practice recommendations for children and adolescents with Rhabdomyosarcoma a joint EpSSG, CWS and ERN PaedCan projecthttps://doi.org/10.1016/j.ejcped.2025.100229
Rhabdomyosarcoma
20248HealthcareSpontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndromehttps://doi.org/10.3324/haematol.2023.283591University of Freiburg, University Hospital Motol, Ghent University Hospital, St. Anna Children’s Hospital, St. Anna Children’s Cancer Research Institute, Aghia Sophia Children’s Hospital, Hannover Medical School, Klinikum rechts der Isar, Technical University of Munich, University Medical Center Augsburg
20247Training and EducationTwinning to reduce research and innovation inequalities in paediatric solid tumours across Europehttps://doi.org/10.1016/j.ejcped.2024.100153Vilnius University Hospital Santaros Klinikos, St. Anna Children’s Cancer Research Institute, University Medical Center Hamburg-Eppendorf
Rigshospitalet, Princess Máxima Center for Pediatric Oncology, Istituto Giannina Gaslini, St. Anna Children’s Hospital 
20245ESCP GuidelineOverview of European standard clinical practice recommendations for multidiscplinary teams involved in the treatment of central nervous system tumours in children and adolescents – SIOPE Brain Tumour Grouphttps://doi.org/10.1016/j.ejcped.2024.100166Princess Máxima Center, UZ Leuven, Azienda Ospedaliera di Padova, Charité Universitätsmedizin Berlin, University Medical Center Hamburg-EppendorfAtypical teratoid rhabdoid tumours (ATRT), Craniopharyngioma, Choroid plexus tumours, Ependymoma, Germ cell tumours (CNS), Glioma ( Low-Grade glioma (LGG), High-Grade glioma (HGG)) , Medulloblastoma, Rare CNS embryonal and sarcomatous tumours
20244ESCP GuidelineEuropean standard clinical practice recommendations for primary pediatric low-grade gliomashttps://doi.org/10.1016/j.ejcped.2024.100169Aghia Sophia Children’s Hospital, Copenhagen University Hospital, Rigshospitalet
Charité Universitätsmedizin Berlin, Princess Máxima Center for Pediatric Oncology
Glioma , Low-Grade 
2024ESCP GuidelineOverview of current European practice for the management of patients with intracranial germ cell tumourshttps://doi.org/10.1016/j.ejcped.2024.100146Germ Cell Tumours (CNS, intracranial) 
20249
Registries
Paediatric very rare tumours registration and management in European countries with low health expenditure average rates
https://doi.org/10.1007/s12094-024-03674-3
Children’s Hospital Zagreb Croatia, University Hospital of Padua, Fondazione IRCCS Istituto Nazionale Tumori, Institut Curie, Marciniak Hospital, Hospital S. João, Medical University of Gdansk, Dortmund Municipal Hospital, Children’s Hospital Eberhard-Karls-Universität
20249CPMSA virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)https://doi.org/10.1016/j.ejcped.2023.100137Dortmund Municipal Hospital, Fondazione IRCCS Istituto Nazionale Tumori, Institut Curie, University Hospital of Padua, Marciniak Hospital, Medical University of Gdansk, Children’s Hospital Zagreb Croatia, Hospital S. João, Children’s Hospital Eberhard-Karls-Universität
2024HealthcareDo national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countrieshttps://doi.org/10.1016/j.lanepe.2024.101155
2024ESCP GuidelineMedulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Reference Network
https://doi.org/10.1016/j.ejcped.2024.100205
Medulloblastoma
2024ESCP GuidelineEuropean standard clinical practice recommendations for paediatric high-grade gliomas
https://doi.org/10.1016/j.ejcped.2024.100210
Glioma, high grade
20234HealthcareRare embryonal and sarcomatous central nervous system tumours:
State-of-the art and future directions
https://doi.org/10.1016/j.ejmg.2022.104660Rigshospitalet Copenhagen Denmark, Charité Universitätsmedizin Berlin, Princess Máxima Center for Pediatric Oncology, Aarhus University Hospital DenmarkMN1-altered Astroblastoma and other rare Embryonal and Sarcomatous Tumours
20239ESCP GuidelineEuropean standard clinical practice – Key issues for the medical care of individuals with familial leukemiahttps://doi.org/10.1016/j.ejmg.2023.104727Hannover Medical School, University of Freiburg, Hôpital Universitaire des Enfants Reine Fabiola, Aarhus University Hospital, Comenius University Medical School and University Children’s Hospital, University of Padova, Ghent University Hospital, Princess Máxima Center for Pediatric Oncology, Università di Milano-Bicocca Monza ItalyFamilial Leukemia
20239+ CCIPatient centerednessSolutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)https://doi.org/10.1016/j.ejcped.2023.100130Clinical Hospital Centre Rijeka Croatia, Medical University of Gdansk Poland, IRCCS Istituto Nazionale Tumori Milan Italy, Institut Gustave Roussy, CCI Europe Austria, University of Padova, Medical University Wroclaw Poland, Dortmund Municipal Hospital Gerrmany, Institut Curie, University Children’s Hospital Tuebingen
20238CPMSA virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)https://doi.org/10.1016/j.ejcped.2023.100137Dortmund Municipal Hospital Gerrmany, IRCCS Istituto Nazionale Tumori Milan Italy, Institut Curie, University Children’s Hospital Tuebingen, University of Padova, Medical University Wroclaw Poland, Medical University of Gdansk Poland, Clinical Hospital Centre Rijeka Croatia
20232 but only from ItalyHealthcareMagnetic resonance imaging characteristics of pediatric pilocytic astrocytomahttps://doi.org/10.1007/s10072-023-06893-8
Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Fondazione IRCCS Policlinico San Matteo Pavia 
20231HealthcareCognitive and Behavioral Outcome of Pediatric Low-Grade Central Nervous System Tumors Treated Only with Surgery: A Single Center Experiencehttps://doi.org/10.3390/diagnostics13091568Fondazione IRCCS Istituto Neurologico Carlo Besta Milan
20236ESCP GuidelineEuropean standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcomahttps://doi.org/10.1016/j.ejcped.2023.100029
Princess Máxima Center for Pediatric Oncology, Karolinska Institutet, Oslo University Hospital, Gustave Roussy, Klinikum Stuttgart Olgahospital, St. Anna Children’s Hospital
Osteosarcoma 
20226ESCP GuidelineNUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendationshttps://doi.org/10.1097/mph.0000000000002568Clinical Hospital Center Rijeka University of Rijeka Croatia, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Dortmund Municipal Hospital, Padova University Hospital, Children’s Hospital Eberhard-Karls-Universität Tübingen, Institut CurieNUT Carcinoma
20222HealthcareA Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Reviewhttps://doi.org/10.3390/jcm11102779
University Hospital Centre Zagreb Croatia, Semmelweis University
2021HealthcareHematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndromehttps://doi.org/10.1038/s41409-021-01374-y
2021EXPeRT Special IssueHealthcareFacing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievementshttps://doi.org/10.1002/pbc.28993
2021EXPeRT Special IssueRegistriesThe European Paediatric Rare Tumours Network – European Registry (PARTNER) project for very rare tumors in childrenhttps://doi.org/10.1002/pbc.29072
2021EXPeRT Special IssueESCP GuidelinePleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.29045
2021EXPeRT Special IssueESCP GuidelinePancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.29112
2021EXPeRT Special IssueESCP GuidelineConsensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescentshttps://doi.org/10.1002/pbc.29017
2021EXPeRT Special IssueESCP GuidelineThymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.29042
2021EXPeRT Special IssueESCP GuidelineNasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.29018
2021EXPeRT Special IssueESCP GuidelineAdrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.29025
2021EXPeRT Special IssueESCP GuidelineSalivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendationshttps://doi.org/10.1002/pbc.29058
2021EXPeRT Special IssueESCP GuidelineCutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationshttps://doi.org/10.1002/pbc.28992
2021HealthcareReview of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancieshttps://doi.org/10.1007/s10689-021-00263-z
2021RegistriesThe impact of incomplete registration on survival rate of children with very rare tumorshttps://doi.org/10.1038/s41598-021-93670-2
2021ESCP GuidelineAdjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)https://doi.org/10.1002/pbc.28963
2018ESCP GuidelineBone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-uphttps://www.annalsofoncology.org/article/S0923-7534(19)31712-0/fulltextAnnals of Oncology
Articles

Media

Subscribe to the newsletters



    You agree to receive email communication from us by submitting this form and understand that your contact information will be stored with us.